|
|
|
Volumn 26, Issue 3 SUPPL. 10, 1999, Pages 15-18
|
|
Docetaxel (Taxotere) in combination with platinum-based regimens in non- small cell lung cancer: Results and future developments
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBOPLATIN;
CISPLATIN;
DOCETAXEL;
PLATINUM DERIVATIVE;
ADULT;
AGED;
AREA UNDER THE CURVE;
CANCER COMBINATION CHEMOTHERAPY;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIARRHEA;
DOSE RESPONSE;
DRUG EFFICACY;
DRUG TOLERABILITY;
FEBRILE NEUTROPENIA;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
LUNG NON SMALL CELL CANCER;
NEUROTOXICITY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
CISPLATIN;
CLINICAL TRIALS;
HUMANS;
LUNG NEOPLASMS;
PACLITAXEL;
TAXOIDS;
|
|
EID: 0032796207
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (17)
|
|
References (31)
|
